McKesson Corporation Reports Fiscal 2014 Fourth-Quarter And Full-Year Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

McKesson Corporation (NYSE:MCK) today reported that revenues for the fourth quarter ended March 31, 2014 were $38.1 billion, up 25% compared to $30.5 billion a year ago. On the basis of U.S. generally accepted accounting principles (“GAAP”), fourth-quarter earnings per diluted share from continuing operations was $1.56 compared to $1.11 a year ago.

Help employers find you! Check out all the jobs and post your resume.

Back to news